|
| Parameters | Number of patients | Patients treated by Stupp protocol | Patients diagnosed with AA | Patients diagnosed with GBM |
|
| Numbers of patients | 87 | 51 | 41 | 46 |
Gender
Male
Female |
43 (49.4%)
44 (50.6%) |
27 (52.9%)
24 (47.1%) |
16 (39%)
25 (61%) |
27 (58.7%)
19 (41.3%) |
Age (years)
median (range) |
48.7 (18–78) |
47 (26–71) |
45 (18–78) |
49.5 (26–78) |
KPS
Mean (range)
KPS > 80
KPS ≤ 80 |
83 (60–100)
40 (46%)
47 (50%) |
90 (70–100)
28 (54.9%)
23 (45.1%) |
90 (70–100)
22 (53.7%)
19 (46.3%) |
80 (70–100)
18 (39.1%)
28 (60.9%) |
RPA
Mean (range) |
4.1 (3–5) |
4 (3–5) |
4 (3–5) |
4 (3–5) |
Histology
Anaplastic astrocytoma
Glioblastoma |
41 (47.1%)
46 (52.9%) |
25 (49%)
26 (51%) |
100%
0 |
0
100% |
Time to recurrence (months)
Mean (range)
≤8 months
9–12 months
>12 months |
13.8 (4–61)
29 (33.3%)
30 (34.5%)
28 (32.2%) |
11 (4–61)
14 (27.4%)
19 (27.3%)
18 (35.3%) |
10 (4–61)
12 (29.3%)
15 (36.6%)
14 (34.1%) |
10 (5–28)
17 (36.9%)
15 (32.6%)
13 (30.5%) |
Tumour volume (cc)
Mean (range)
<3 cc
4–7 cc
>7 cc |
8.7 (1–42.6)
29 (33.3%)
26 (29.9%)
32 (36.8%) |
4 (0.36–34.1)
16 (31.4%)
22 (43.1%)
13 (25.5%) |
5.2 (1–28)
12 (29.3%)
12 (29.3%)
17 (41.4%) |
4 (0.05–34.1)
17 (37%)
14 (30.4%)
15 (32.6%) |
Location
Unifocal
Multifocal |
79 (90.8%)
8 (9.2%) |
45 (88.2%)
6 (11.8%) |
39 (95.1%)
2 (4.9%) |
40 (87%)
6 (13%) |
Dose radiosurgery
Mean (range)
Dose ≥ 18 Gy |
18.01 Gy (14–20)
76 (87%) |
18 Gy (16–20)
46 (90.2%) |
18 (15–20)
35 (85.4%) |
18 Gy (14–20)
41 (89.1%) |
PTV margin
Mean (range)
0 mm
1–3 mm
>3 mm |
1.67 mm (0–6)
43 (49.4%)
22 (25.3%)
22 (25.3%) |
2 mm (0–6)
20 (39.2%)
10 (19.6%)
21 (41.2%) |
2 mm (0–5)
19 (46.3%)
12 (29.3%)
10 (24.4%) |
0 mm (0–6)
24 (52.2%)
10 (21.7%)
12 (26.1%) |
|
